DeutschEnglish

Clemens von Pirquet-Preis für Allergieforschung


Dank einer Stiftung der Firma ALK-Abelló GmbH (vormals Epipharm) konnte von 1985 bis 2012 der Clemens von Pirquet-Preis für hervorragende Arbeiten auf dem Gebiet der Allergieforschung ausgeschrieben werden. Mit Ausnahme der Jahre 1985 und 1987 wurde dieser Preis jährlich vergeben.Ab 2013 wird dieser Preis von der Fa. Bencard Allergie gestiftet.

Jahr Preisträger Titel der prämierten Arbeit Literaturstelle

1985

keine Vergabe

 

 

1986

Hugo Wolf
Institut für Allgemeine und Experimentelle Pathologie Innsbruck

Detection of antibodies interacting with glycosaminoglykan polysulfate in patients treated with heparin or other polysulfated glycosaminoglykans

Identification of binding site for heparin and other polysulfated glycosaminoglycans on human thrombocytes.

Int. Arch. Allergy Appl. Immunol. 1983; 70:157-63

 

Int. Arch. Allergy Appl. Immunol. 1986; 80: 231-8

1987

keine Vergabe

 

 

1988

Heimo Breiteneder 
Institut für Allgemeine und Experimentelle Pathologie, Wien

Isolation and characterization of messenger RNA from male inflorescences and pollen of the white birch (Betula verrucosa)

Int. Arch. Allergy Appl. Immunol. 1988; 87: 19-24

1989

Heimo Breiteneder
Institut für Allgemeine und Experimentelle Pathologie, Wien

The gene coding for the major birch pollen allergen Bet v I is highly homologous to a pea disease resistance response gene

EMBO J. 1989; 8: 1935-8

1990

Hannes Stockinger 
Institut für Immunologie, Wien

Human blood basophils synthesize interleukin-2 binding sites.

Blood 1990; 75: 
1820-6

1991

Rudolf Valenta
Institut fur Allgemeine und Experimentelle Pathologie, Wien

Homology of the major birch-pollen allergen, Bet v I, with the major pollen allergens of alder, hazel, and hornbeam at the nucleic acid level as determined by cross-hybridization

J. Allergy Clin. Immunol. 1991; 87: 677-82

1992

Georg Stingl
Universitätssklinik für Dermatologie, Wien

Epidermal Langerhans cells from normal human skin bind monomeric IgE via FceRI

J. Exp. Med. 1992; 175: 1353-65

1993

Peter Kulmburg
Department of Immunopharmacology, Sandoz Forschungsinstitut, Wien

Immunoglobulin E plus antigen challenge induces a novel intercrine/chemokine in mouse mast cells

J. Exp. Med. 1992; 176: 1773-8

1994

Dieter Maurer
Universitätsklinik Dermatologie, Wien

Expression of functional high affinity immunoglobulin E receptors (Fc-epsilon RI) on monocytes of atopic individuals

J. Exp. Med. 1994; 179: 745-50

1995

Tanja Ball
Institut für Allgemeine und Experimentelle Pathologie, Wien

Isolation of an immunodominant IgE hapten from an epitope expression cDNA library. Dissection of the allergic effector reaction.

J. Biol. Chem. 1994; 269: 28323-8

1996

Fatima Ferreira
Institut für Allgemeine und Experimentelle Pathologie, Wien

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v I: Potential use of hypoallergenic isoforms for immunotherapy

J. Exp. Med. 1996; 183: 599-609

1997

Susanne Vrtala 
Institut für Allgemeine und Experimentelle Pathologie, Wien

Conversion of the major birch pollen allergen Bet v 1, into nonanaphylactic T cell epitope-containing fragments: Candidates for novel form of specific immunotherapy.

J. Clin. Invest. 1997; 99:1673-81.

1998

Susanne Vrtala 
Institut für Allgemeine und Experimentelle Pathologie, Wien

Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen
interaction and allergen-induced basophil degranulation.

J. Immunol. 1998;
160: 6137-44.

1999

Eva Prieschl
Department of Immunology 
Novartis Research Institute, Wien

The balance between sphingosine and sphingosine-1-phoasphat is decisive for mast cell activation after Fc-epsilon RI triggering.

J. Exp. Med. 1999;
190: 1-18.

2000

Erika Jensen-Jarolim 
Institut für Allgemeine und Experimentelle Pathologie, Wien

Allergen mimotopes in food enhance type I allergic reactions in mice

FASEB J. 1999; 13:1586-92.

2001

Erika Ganglberger
Institut für Allgemeine und Experimentelle Pathologie, Wien

Allergen-mimotope search, and induction of antibodies.

FASEB J. 2000; 14: 2177-84

2002

Erika Ganglberger 
Institut für Pathophysiologie, Wien

Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergy.

FASEB J. 2001; 15: 2524-6.

2003

Eva Untersmayr, Institut für Pathophysiologie der Universität Wien

Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice.

J. Allergy Clin. Immunol. 2003; 112: 616-23

2004

Günther Lametschwandtner, Novartis Forschungsinstitut Wien

Sustained T-bet expression confers polarized human TH2 cells with TH1-like cytokine production and migratory capacities. 

J. Allergy Clin. Immunol. 2004;
113: 987-94.

2005

Beatrice Jahn-Schmid,
Institut f. Pathophysiologie, Wien

Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1*01

 J. Allergy Clin. Immunol. 2005; 115: 399-404

2006

Barbara Bohle, Institut f. Pathophysiologie, Med.Uni.Wien 

Cooking birch pollen-related food: divergent consequences for IgE-and T cell-mediated reactivity

J Allergy and Clin Immunol 2006;118:242-249

2007

Tamara Kinaciyan, Univ.-Klinik f.Dermatologie, Med.Uni.Wien

Successful sublingual immunotherapy with birch pollen has limited effects on concommittant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1

J Allergy and Clin Immunol 2007; 119-937

2007

Birgit Linhart, Institut f.Pathophysiologie, Med.Uni.Wien

Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy

J.Immunol 2007; 178:3924-3931

2008

Michael Wallner, Univ.Salzburg, FB Molekulare Biologie

Allergy multivaccines created by DNA shuffling of tree pollen allergens

J.Allergy Clin.Immunol (2007) 120:374-380

2009

Victoria Leb-Reichl, Inst.f.Immunologie, Med.Uni.Wien

Modulation of allergen-specific T-lymphocyte function by virus-like particles decorated with HLA class II molecules

J.Allergy Clin.Immunol. (20009) 124:121-128

2009

Christian Radauer, Inst.f.Pathophysiologie, Med.Univ.Wien

Allergens are distributed into few protein families and possess a restricted number of biochemical functions

J.Allergy Clin.Immunol. (2008) 121:847-852

2010

Irene Mittermann, Inst.f.Pathophysiologie, Med.Univ.Wien

Recombinant allergen-based IgE testing to distinguish bee and wasp allergy

J.Allergy Clin.Immunol. (2010) 125:1300

2011

Katarzyna Niespodziana, Inst.f.Pathophysiologie, Med.Univ.Wien

A hypoallergic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS

J.Allergy Clin.Immunol. 127:1562, 2011

2012

Alina Neunkirchner, Inst.f.Immunologie, Med.Univ.Wien

Human TCR transgenic Bet v 1-specific Th1 cells suppress the effector function of Bet v 1-specific Th2 cells

J.Immunol. 187:4077, 2011

2013

Elisabeth Gadermaier, Inst.f.Pathophysiologie, Med.Univ.Wien

Determination of allergen specificity by heavy chains in grass pollen allergen specific IgE antibodies

J.Allergy Clin.Immunol. 131:1185, 2013

2014

Marija Geroldinger-Simic, Krkh.d.Elisabethinen, Linz

Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy

J.Allergy Clin.Immunol. 131:94, 2013

2015

Claudia Kitzmüller,
Inst.f. Pathophysiologie und Allergieforschung, Med.Univ.Wien

Correlation of sensitizing capacity and T-cell recognition within the Bet v 1 family

J Allergy Clin Immunol 2015 136(1):151-8

2016

Anna Gieras
Inst.f. Pathophysiologie und Allergieforschung, Med.Univ.Wien

IgE epitope proximity determines immune complex shape and effector cell activation capacity.

J Allergy Clin Immunol 2015 137(5):1557-1565

 




 
 


Wir danken den unterstützenden Mitgliedern:


alkabello
allergopharma
astrazeneca
Shire
bd
affymetrix_bioscience
biomedica
eubio
gsk
meda
morpho
novartis
thermofisher
szabo